These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2294689)

  • 21. Contribution of delayed ventricular repolarization to the anti-arrhythmic efficacy of sotalol.
    Brachmann J; Senges J; Lengfelder W; Jauernig R; Rizos I; Czygan E; Cobbe SM; Kübler W
    Eur Heart J; 1985 Nov; 6 Suppl D():171-4. PubMed ID: 3936715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease.
    Kus T; Campa MA; Nadeau R; Dubuc M; Kaltenbrunner W; Shenasa M
    Am Heart J; 1992 Jan; 123(1):82-9. PubMed ID: 1729853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of sotalol guided by programmed electrical stimulation for sustained ventricular arrhythmias secondary to coronary artery disease.
    Young GD; Kerr CR; Mohama R; Boone J; Yeung-Lai-Wah JA
    Am J Cardiol; 1994 Apr; 73(9):677-82. PubMed ID: 8166065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Nademanee K; Feld G; Hendrickson J; Singh PN; Singh BN
    Circulation; 1985 Sep; 72(3):555-64. PubMed ID: 4017207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia.
    Antz M; Cappato R; Kuck KH
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):627-35. PubMed ID: 8569226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease.
    Miyazaki A; Ohuchi H; Kurosaki K; Kamakura S; Yagihara T; Yamada O
    Circ J; 2008 Dec; 72(12):1998-2003. PubMed ID: 18931451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of sotalol for life-threatening ventricular arrhythmias.
    Roden DM
    Am J Cardiol; 1993 Aug; 72(4):51A-55A. PubMed ID: 8346727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
    Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M
    Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of sotalol and procainamide in symptomatic ventricular tachycardia.
    Jordaens LJ; Colardyn F; Clement DL
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):155-61. PubMed ID: 2487531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized crossover comparison of the electrophysiologic and antiarrhythmic efficacy of oral cibenzoline and sotalol for sustained ventricular tachycardia.
    Hoffmann E; Mattke S; Haberl R; Steinbeck G
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):95-100. PubMed ID: 7678686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid intravenous infusion of d-1 sotalol: time to onset of effects on ventricular refractoriness, and safety.
    Ho DS; Zecchin RP; Cooper MJ; Richards DA; Uther JB; Ross DL
    Eur Heart J; 1995 Jan; 16(1):81-6. PubMed ID: 7737227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and proarrhythmia of oral sotalol in pediatric patients.
    Pfammatter JP; Paul T; Lehmann C; Kallfelz HC
    J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolving role of sotalol in the management of ventricular tachyarrhythmias.
    O'Callaghan PA; McGovern BA
    Am J Cardiol; 1996 Aug; 78(4A):54-60. PubMed ID: 8780329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Trappe HJ; Klein H; Lichtlen P
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1425-32. PubMed ID: 2278875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of oral sotalol in reentrant ventricular tachycardia.
    Obel IW; Jardine R; Haitus B; Millar RN
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():613-8. PubMed ID: 2275891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of sotalol and class I antiarrhythmic agents in patients with ventricular tachycardia or fibrillation: results of the Electrophysiology Study Versus Electrocardiographic Monitoring (ESVEM) Trial.
    Klein RC
    Eur Heart J; 1993 Nov; 14 Suppl H():78-84. PubMed ID: 8293756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: a double-blind, randomized parallel evaluation. Sotalol Multicenter Study Group.
    Singh BN; Kehoe R; Woosley RL; Scheinman M; Quart B
    Am Heart J; 1995 Jan; 129(1):87-97. PubMed ID: 7817931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia.
    Senges J; Lengfelder W; Jauernig R; Czygan E; Brachmann J; Rizos I; Cobbe S; Kübler W
    Circulation; 1984 Mar; 69(3):577-84. PubMed ID: 6692518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproducible induction of "atypical" torsades de pointes by programmed electrical stimulation: a novel form of sotalol-induced proarrhythmia?
    Krishnan SC; Galvin J; McGovern B; Garan H; Ruskin JN
    J Cardiovasc Electrophysiol; 1997 Sep; 8(9):1055-61. PubMed ID: 9300303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP; Reid PR; Platia EV; Griffith LS
    Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.